| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |